Risk factor
Very high price volatility
Profitability factor
Undervalued vs peers
About
Viva Biotech Holdings, an investment holding company, provides structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides discovery biology services, include protein expression and purification, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacokinetics; chemistry services, such as medicinal and synthetic chemistry, analytical chemistry, purification preparation, and computer-aided drug design services,...
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. In particular, the stock is reasonably priced on P/E, 'cheap' on EV/EBITDA, trading at neut
Target Price
The average target price of 1873.HK is 3.3 and suggests 42% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell